Valor total de mercado:$00
API
PT
Escuro

PesquisarSSI/Mag7/Meme/ETF/Moeda/Índice/Gráficos/Pesquisa
00:00 / 00:00
Visualizar
    Mercados
    Índexes
    Feed de notícias
    TokenBar®
    Análise
    Macro
    Favoritos
Revolução da pesquisa de investimento em criptomoedas impulsionada por IA

Prenetics

$8.05+2.03%
PRENASDAQ
Volume de negócios:
$289,284.49
Capitalização de mercado total:
$102,838,110.09
Capitalização de mercado circulante:
$72,402,853.26
Taxa de rotatividade:
0.39%
Notícias
Anúncio
Ver mais
Digitalize o QR Code p/ explorar mais info chave

Prenetics

PRE

Sheng Wu Yeung
Co-Founder, Chairperson & CEO
Dr. Chi Hung Tzang Ph.D.
Co-Founder & Chief Scientific Officer
Hoi Chun Lo
Chief Financial Officer
Samantha Kwok
Chief of Staff to Group CEO & Vice President of People & Operations
Dr. Senthil Kumar Sundaram M.D.
Chief Clinical Officer
Joel Neoh
Chief Consumer Officer
David Eric Vanderveen
Director & President of Americas
James DiNicolantonio
Chief Nutrition Officer, Member of Scientific & Medical Advisory Board
Prenetics
PRE
Crypto Treasury
NASDAQ
$8.05
+2.03%
Preço de fechamento 07/14 16:00 EST
$8.050.00%
Preço pós-horário 07/14 17:33 EST
Volume de negócios
$289,284.49
Volume
35,940
Taxa de rotatividade
0.39%
Preço máximo diário
$8.19
Preço mínimo diário
$7.91
Capitalização de mercado total
$102,838,110.09
Capitalização de mercado circulante
$72,402,853.26
PE TTM
-2.07
PB
0.64
Informações
Prenetics Global Limited is a health sciences company, which engages in the provision of early detection, prevention, and treatment of cancer. It operates through following segments: Consumer Health, Prevention and Diagnostics. The Consumer Health segment focuses on IM8 a health and wellness brand which focuses on consumer health products and Europa, a U.S. sports distribution company. The Prevention segment focuses on its CircleDNA and ACT Genomics business units. The CircleDNA business unit uses next-generation sequencing (NGS) technology for consumer deoxyribonucleic acid (DNA) test. The Diagnostics segment focuses on ACT Genomics business unit is involved in genomic profiling of solid tumors. It has a presence in the United States. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.
Leia mais
Data de listagem
2021-07-16
Setor
Crypto Treasury
Bolsa de valores
NASDAQ
Site
prenetics.com
Mídias sociais
twitter
TermosPolítica de PrivacidadePapel BrancoVerificação oficialCookieBlogue
sha512-gmb+mMXJiXiv+eWvJ2SAkPYdcx2jn05V/UFSemmQN07Xzi5pn0QhnS09TkRj2IZm/UnUmYV4tRTVwvHiHwY2BQ==
sha512-kYWj302xPe4RCV/dCeCy7bQu1jhBWhkeFeDJid4V8+5qSzhayXq80dsq8c+0s7YFQKiUUIWvHNzduvFJAPANWA==